Night shift work disrupts the natural 24-hour rhythms in the activity of certain cancer-related genes, making workers more vulnerable to damage to their DNA.
PNNL computational biologists, structural biologists, and analytical chemists are using their expertise to safely accelerate the design step of the COVID-19 drug discovery process.
In a new video series this fall, PNNL is highlighting six scientific and technical experts in the national security domain. Each was promoted to Scientist and Engineer Level 5, one of PNNL’s most senior research roles.
Five PNNL technologies were recently awarded six R&D 100 honors. The R&D 100 Awards, now in its 58th year, recognize pioneers in science and technology from industry, the federal government, and academia.
A technology that can quickly detect explosive vapors, deadly chemicals and illicit drugs with unparalleled accuracy has been named the 2020 Innovation of the Year by GeekWire, the Seattle-based technology news company.
By studying discrete functional components of the soil microbiome at high resolution, researchers obtained a more complete picture of soil diversity compared to analysis of the entire soil community.
Six months into a pandemic that has claimed more than 570,000 lives worldwide, scores of PNNL scientists are engaged in dozens of projects in the fight against COVID-19.
Accurate identification of metabolites, and other small chemicals, in biological and environmental samples has historically fallen short when using traditional methods.
A new study using proteogenomics to compare cancerous tissue with normal fallopian tube samples advances insights about the molecular machinery that underlies ovarian cancer.
Pointing the finger at chemical criminals: Several scientists from PNNL and other institutions will discuss new methods and approaches at the American Chemical Society's national meeting in San Francisco April 2-6.